<Suppliers Price>

PRIMOCARCIN

Names

[ CAS No. ]:
3750-26-3

[ Name ]:
PRIMOCARCIN

[Synonym ]:
Primocarcin,5-Acetamino-4-oxohex-5-ensaeureamid
5-Hexenamide,5-(acetylamino)-4-oxo
Primocarcin
5-HEXENAMIDE,5-ACETAMIDO-4-OXO
5-Acetamino-4-oxo-hex-5-ensaeure-amid
5-(Acetylamino)-4-oxo-5-hexenamide
4-Acetamido-4-penten-3-one-1-carboxamide

Chemical & Physical Properties

[ Density]:
1.155g/cm3

[ Boiling Point ]:
544.5ºC at 760 mmHg

[ Molecular Formula ]:
C8H12N2O3

[ Molecular Weight ]:
184.19200

[ Flash Point ]:
283.1ºC

[ Exact Mass ]:
184.08500

[ PSA ]:
89.26000

[ LogP ]:
0.56200

[ Index of Refraction ]:
1.487

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MP6475000
CHEMICAL NAME :
5-Hexenamide, 5-acetamido-4-oxo-
CAS REGISTRY NUMBER :
3750-26-3
LAST UPDATED :
199712
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C8-H12-N2-O3
MOLECULAR WEIGHT :
184.22
WISWESSER LINE NOTATION :
ZV2VYU1&MV1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
55500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JAJAAA Journal of Antibiotics, Series A. (Tokyo, Japan) V.6-20, 1953-67. For publisher information, see JANTAJ. Volume(issue)/page/year: 15,250,1962
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JAJAAA Journal of Antibiotics, Series A. (Tokyo, Japan) V.6-20, 1953-67. For publisher information, see JANTAJ. Volume(issue)/page/year: 15,77,1962

Safety Information

[ HS Code ]:
2924199090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2924199090

[ Summary ]:
2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%